| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
| mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.05 |
| mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |